RT Journal Article
SR Electronic
T1 Improving the Diagnosis of SIBO Using an At-Home Handheld App Connected Breath Analysis Device (AIRE)
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.04.21.22274143
DO 10.1101/2022.04.21.22274143
A1 Barahona, Guillermo
A1 Mc Bride, Barry
A1 Moran, Áine
A1 Hawamdeh, Sahar
A1 Villatoro, Luisa
A1 Burns, Robert
A1 Konings, Bo
A1 Bulat, Robert
A1 McKnight, Megan
A1 Shortt, Claire
A1 Pasricha, Pankaj J.
YR 2022
UL http://medrxiv.org/content/early/2022/04/21/2022.04.21.22274143.abstract
AB INTRODUCTION Small Intestinal Bacterial Overgrowth (SIBO) is a common yet underdiagnosed condition. Lactulose hydrogen breath tests (LHBT) are typically used to detect SIBO; however, current breath testing methods require specialised, expensive equipment and technical support and are either done at a point-of-care facility and/or have to be mailed to a central laboratory. To address these issues a novel hand-held breath analyzer (AIRE®, FoodMarble) was tested. The aims of this study were first, to perform a technical assessment of the AIRE device, second to compare the performance of the AIRE device against a commercially available mail-in LHBT kit using a zero-inflated negative binomial mixed effect model.METHODS Three AIRE devices were tested with certified test gases covering a diagnostically meaningful range (hydrogen mixed with air at 3 ppm, 10 ppm and 50 ppm). For the clinical study, 36 patients suspected to have SIBO presenting to a tertiary level clinic were provided with an AIRE device and performed concurrent LHBTs at home with a mail-in LHBT kit.RESULTS The overall average readings (mean ± SD) for the AIRE devices tested at 3 ppm, 10 ppm and 50 ppm H2 were: 3.5 ± 0.7 ppm; 10.7 ± 1.1 ppm and 49.5 ± 2.6 ppm respectively. The overall mean absolute error across the tested devices was 1.2 ppm. A significant positive correlation (r = 0.78, p < 0.001) was demonstrated between AIRE and mail-in kit H2 values.DISCUSSION The AIRE device is a compelling alternative to mail-in LHBT kits for the diagnosis of SIBO. The AIRE device may also offer advantages over other traditional breath testing methods.Competing Interest StatementAine Moran, Barry Mc Bride and Claire Shortt are employees of FoodMarble Digestive Health. Sahar Hawamdeh is a former employee of FoodMarble Digestive Health. Pankaj J. Pasricha is a member of the clinical advisory board of FoodMarble Digestive Health. Clinical TrialNCT04309396Funding StatementThe study materials support was provided by FoodMarble Digestive Health Limited.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee/IRB of Johns Hopkins University gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.